-
COVER STORY
Olon: high-quality peptides through an innovative technological platform
-
EDITORIAL
Inside the (self-driving) lab of the future
A. Aspuru-Guzik
-
NEWS
-
PHARMA SUPPLY CHAIN
Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic
A. M. Gaffney
-
PRODUCT FOCUS
Angelini – Flow chemistry as novel chirotechnologic tool for asymmetric synthesis of apis
-
EXCIPIENTS
Incorporation of excipients into QbD studies for product development and lifecycle management
R. C. Moreton
-
CONTRACT MANUFACTURING
Reshoring: tips and tricks
I. Caldera, A. Conto
-
COMPANY PROFILE
Asymchem – A best-in-class approach to accelerating the manufacturing of your Oligonucleotide drug substance
-
PROCESS ENGINEERING
Statistical Predictive Models for Process Control in Biopharmaceutical Filtration and Chromatography
S. Ruane, E. Lopez-Montero, J. Fung, D. A. Whitaker
-
FLOW CHEMISTRY
Successfully track materials in continuous processes – Using PAT to improve material management in flow chemistry applications
M. Gadsby, E. Hillier
-
DIGITALIZATION
Benefits of a digital operations platform In the context of pharmaceutical and chemical industries
I. O. Esko, P. B. Docherty
-
A WORD WITH
Enrico Zodio, CEO, Procos
-
HPAPIs
Handling HPAPIs for maximum manufacturing flexibility while maintaining adequate safety controls
S. Baron, W. Dubay
-
A WORD WITH
Gianni Faggi, CEO, Faggi
-
APIS
An executive order for US API and drug supply chains: Examining white house policy recommendations
M. Hicks, P. Stevens
-
A WORD WITH
Luca Crippa, CEO & Managing Director, IBSA Farmaceutici
-
Column: REGULATION
Nitrosamine in drug products: an open discussion
A. Conto
-
A WORD WITH
Giancarlo Guglielmini, Business Unit Manager Pharmaceutical Division, amita health care Italia s.r.l
-
EVENTS
REPORT – Workshop on Circular economy and Catalysis at Faggi’s facility
-
PACKAGING
Redefining pharma containers for enhanced inclusion: improving usability and therapy adherence for patients with disabilities and elderly individuals
F. Piutti
-
A WORD WITH
Manjit Singh, Chair of the PSCI
-
BIOCATALYSIS
Engineering of immobilised enzyme biocatalysts for reaction intensification
A. Garcia-Martin, A. Lorente-Arevalo, M. Ladero, J. M. Bolivar
-
MERGERS & ACQUISITIONS
The challenges of a changing pharmaceutical manufacturing landscape
F. Walton, J. Jacob